摘要
目的利用溶血指数(HI)评价标本质量,避免临床实验室分析的干扰。方法采集临床4 572份血液标本,采用Vitros 5600生化免疫分析仪检测血液标本的HI,将HI≥15的溶血标本分为6组(其中HI分别为15～24、25～50、51～100、101～150、151～200、>200),统计各组溶血标本的分布以及所占比例。结果 4 572份血液标本中,HI≥15的溶血标本占7.06%(323/4 572)。HI≥15的323份溶血标本中,HI为15～100的溶血标本占96.90%(313/323),其中HI为51～100的溶血标本所占比例为8.98%(29/323)。结论生化免疫分析仪HI可用于检测溶血程度和评价干扰,目测溶血程度可能影响患者安全。
Objective To use hemolysis index（HI） to evaluate samples quality in order to avoid interference due to analysis in clinical laboratory. Methods Four thousand five hundred and seventy-two clinical blood samples were collected, and HI was estimated by Vitros 5600 Biochemistry Immunity Analyzer. HI sample values ≥15 were categorized into 6 groups： HI 15-24, 25-50, 51-100, 101-150, 151-200, 200 groups, respectively. The hemolysis distribution and its proportion in the samples were statistically analyzed. Results Of 4 572 blood samples, the percentage of hymolysis samples HI ≥15 was accounting for 7.06%（323/4 572）. Of 323 HI ≥15 samples, the percentage of HI 15-100 hymolysis samples was 96.90%（313/323）, and of 323 HI ≥15 samples, the percentage of HI 51-100 hymolysis samples was 8.98%（29/323）. Conclusions The HI determination by Vitros 5600 Biochemistry Immunity Analyzer can be used for detecting sample hemolysis degree and evaluating interference. Visual assessment of hemolysis degree may affect patients＇ safety.
作者
杨琦
张兰
田丽春
韩冉
寿好长
Yang Qi;Zhang Lan;Tian Lichun;Han Ran;Shou Haochang(Department of Laboratory,Donjang Hospital Affiliated to Beijing University of Chinese Medicine,Beijing 100078,China)
出处
《实用检验医师杂志》
2018年第3期141-142,共2页
Chinese Journal of Clinical Pathologist
关键词
生化免疫分析仪
溶血指数
干扰
分析前误差
Biochemistry immunity analyzer
Hemolysis index
Interference
Pre-analytical errors
